Institutional Ownership Verve Therapeutics, Inc. (VERV)
This table provides information about the institutional ownership of Verve Therapeutics, Inc. (VERV). We have compiled data on the 199 institutions that hold shares in the stock, with a total of 79.5 Million shares, which have been reported (via 13F filing form) to have a value of $870 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Balyasny Asset Management LLC
Chicago, IL |
May 15, 2025 Q1 2025 |
604,749
shares
|
$6.61 Million
0.0% of portfolio
|
Q1 2025
Added 610.5%
|
|
|
Trexquant Investment LP
Stamford, CT |
May 14, 2025 Q1 2025 |
588,417
shares
|
$6.43 Million
0.03% of portfolio
|
Q1 2025
Reduced 7.46%
|
|
|
Palo Alto Investors LP
Palo Alto, CA |
May 15, 2025 Q1 2025 |
575,817
shares
|
$6.29 Million
0.53% of portfolio
|
Q4 2023
New holding
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
May 09, 2025 Q1 2025 |
568,184
shares
|
$6.21 Million
0.0% of portfolio
|
Q1 2025
Reduced 0.44%
|
|
|
Dimensional Fund Advisors LP
Austin, TX |
May 13, 2025 Q1 2025 |
444,509
shares
|
$4.86 Million
0.0% of portfolio
|
Q1 2025
Added 1.7%
|
|
|
Two Sigma Investments, LP
New York, NY |
May 15, 2025 Q1 2025 |
379,581
shares
|
$4.15 Million
0.0% of portfolio
|
Q1 2025
Reduced 33.44%
|
|
|
Aqr Capital Management LLC
Greenwich, CT |
May 15, 2025 Q1 2025 |
373,207
shares
|
$4.08 Million
0.0% of portfolio
|
Q1 2025
Added 1028.74%
|
|
|
Ikarian Capital, LLC
Dallas, TX |
May 15, 2025 Q1 2025 |
358,393
shares
|
$3.92 Million
0.23% of portfolio
|
Q1 2025
Added 110.83%
|
|
|
Jpmorgan Chase & CO
New York, NY |
May 12, 2025 Q1 2025 |
316,179
shares
|
$3.46 Million
0.0% of portfolio
|
Q1 2025
Reduced 24.28%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
May 15, 2025 Q1 2025 |
311,480
shares
|
$3.4 Million
0.0% of portfolio
|
Q1 2025
Added 141.08%
|
|
|
Susquehanna Fundamental Investments, LLC
Bala Cynwyd, PA |
May 14, 2025 Q1 2025 |
284,237
shares
|
$3.11 Million
0.02% of portfolio
|
Q1 2025
Reduced 2.45%
|
|
|
Wade G W & Inc
Wellesley, MA |
Feb 08, 2024 Q4 2023 |
259,626
shares
|
$2.84 Million
0.12% of portfolio
|
Q1 2023
Reduced -0.0%
|
|
|
Wellington Management Group LLP
Boston, MA |
May 13, 2025 Q1 2025 |
244,183
shares
|
$2.67 Million
0.0% of portfolio
|
Q1 2025
New holding
|
|
|
Barclays PLC
London, X0 |
May 15, 2025 Q1 2025 |
186,968
shares
|
$2.04 Million
0.0% of portfolio
|
Q1 2025
Reduced 15.3%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
May 14, 2025 Q1 2025 |
180,800
shares
|
$1.98 Million
0.0% of portfolio
|
Q1 2025
Reduced 50.25%
|
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
May 15, 2025 Q1 2025 |
173,800
shares
|
$1.9 Million
0.0% of portfolio
|
Q1 2025
Reduced 40.72%
|
|
|
Acuta Capital Partners, LLC
Belmont, CA |
May 15, 2025 Q1 2025 |
162,724
shares
|
$1.78 Million
1.41% of portfolio
|
Q1 2025
Added 1.58%
|
|
|
Pfm Health Sciences, LP
San Francisco, CA |
May 15, 2025 Q1 2025 |
155,495
shares
|
$1.7 Million
0.06% of portfolio
|
Q1 2025
Added 23.41%
|
|
|
American Century Companies Inc
Kansas City, MO |
May 13, 2025 Q1 2025 |
150,876
shares
|
$1.65 Million
0.0% of portfolio
|
Q1 2025
Added 18.37%
|
|
|
Stifel Financial Corp
St. Louis, MO |
May 13, 2025 Q1 2025 |
145,377
shares
|
$1.59 Million
0.0% of portfolio
|
Q1 2025
Added 3.0%
|
|
|
Citigroup Inc
|
May 12, 2025 Q1 2025 |
140,870
shares
|
$1.54 Million
0.0% of portfolio
|
Q1 2025
Added 18.94%
|
|
|
Mirae Asset Global Etfs Holdings Ltd.
Central, K3 |
May 15, 2025 Q1 2025 |
140,727
shares
|
$1.54 Million
0.0% of portfolio
|
Q1 2025
Reduced 2.78%
|
|
|
Ubs Asset Management Americas Inc
Chicago, IL |
May 19, 2025 Q1 2025 |
133,566
shares
|
$1.46 Million
0.0% of portfolio
|
Q1 2025
Added 11.47%
|
|
|
Ubs Group Ag
|
May 13, 2025 Q1 2025 |
131,773
shares
|
$1.44 Million
0.0% of portfolio
|
Q1 2025
Reduced 5.73%
|
|
|
Algert Global LLC
San Francisco, CA |
May 13, 2025 Q1 2025 |
128,915
shares
|
$1.41 Million
0.01% of portfolio
|
Q1 2025
Reduced 31.43%
|